Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
Schizophrenia (SCH) is a heterogeneous disorder, deriving from a potential multitude of etiopathogenetic factors. During the past few years there has been an increasing interest in the role of circulating amino acids (AAs) and biogenic amines (BAs) in the pathophysiology of SCH. In the present study...
Main Authors: | Liisa Leppik, Kärt Kriisa, Kati Koido, Kadri Koch, Kärolin Kajalaid, Liina Haring, Eero Vasar, Mihkel Zilmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fpsyt.2018.00155/full |
Similar Items
-
Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
by: Kärt Kriisa, et al.
Published: (2016-01-01) -
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
by: Madis Parksepp, et al.
Published: (2020-08-01) -
Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
by: Eero Vasar, et al.
Published: (2016-07-01) -
Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
by: Yoshie Omachi, et al.
Published: (2018-09-01) -
Prescription patterns of antipsychotics in the management of first episode psychosis at three psychiatric hospitals in Khartoum, 2018: A descriptive cross-sectional study
by: Malaz M A Mohamed, et al.
Published: (2020-01-01)